Organisation paid for research Program year 2020 Source: CMS Open Payments

Clinsite LLC

Neither a doctor nor a teaching hospital

Research payments

$235,874

26 payments

Through program year 2020, Clinsite LLC is reported as receiving $235,874 in research payments, across 26 payments.

By program year

2 rows
Year Kind Amount Payments
2020 Research $147,992 2
2019 Research $87,882 24

Breakdown

Who paid Research payments · program years 2019–2020
  1. Pfizer Inc. $177,412 15 payments
  2. Novo Nordisk AS $41,868 10 payments
  3. Sanofi-Aventis U.S. LLC $16,594 1 payment
Studies the money was for Research payments · program years 2019–2020
  1. A Phase 3 Placebocontrolled Randomized Observerblinded Study to Evaluate the Efficacy Safety and Tolerability of A Clostridium Difficile Vaccine in Adults 50 Years of Age and Older $177,412 15 payments
  2. Ex9536-4388 $31,868 9 payments
  3. A 26-week Randomized, Open-label, Active-controlled, 2-treatment Arm, Parallel Group Multi-center Study, Comparing the Efficacy and Safety of Soliqua 100/33 Versus Lantus in Ethnically/Racially Divers $16,594 1 payment
  4. Nn9924-4221 $10,000 1 payment

What you are looking at

A noncovered recipient is an organisation paid for research that is neither an individual clinician nor a teaching hospital — typically a contract research organisation, a foundation or a trial site network. They receive 81% of all reported research money, which is why they appear here at all.

Provenance

Source: CMS Open Payments · through program year 2020

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record